City

Clinical trials near Sherbrooke, Canada

Active studies with a listed research site in Sherbrooke, Canada.

13active studies

4recruiting now

21countries represented

193largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, OverweightCondition

BI 3034701, Placebo matching BI 3034701Treatment

Australia, Canada54 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07662122See eligibility →

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Obesity or Overweight, Type 2 Diabetes MellitusCondition

Placebo, EnicepatideTreatment

Argentina, Australia193 locations

Hoffmann-La RocheSponsor

Updated 2026-08-14 · NCT07351058See eligibility →

Recruiting nowNot applicable

Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in Preconception

Overweight and Obesity, Pregnancy ComplicationsCondition

Healthy for my Baby, Usual CareTreatment

Canada2 locations

Université de SherbrookeSponsor

Updated 2025-04-02 · NCT04242069See eligibility →

Opening soonNot applicable

How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver

Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH)Condition

Imaging PET/MRI, Stable isotope infusionsTreatment

Canada1 locations

Université de SherbrookeSponsor

Updated 2025-08-21 · NCT07133854See eligibility →

Active, not recruitingPhase 1, Phase 2

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Overweight and ObesityCondition

AZD9550, placeboTreatment

Austria, Canada15 locations

AstraZenecaSponsor

Updated 2026-08-26 · NCT06151964See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Obesity, OverweightCondition

RetatrutideTreatment

Argentina, Canada35 locations

Eli Lilly and CompanySponsor

Updated 2026-06-09 · NCT07357415See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Active, not recruitingPhase 3

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Type 1 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Brazil79 locations

Eli Lilly and CompanySponsor

Updated 2026-02-17 · NCT06962280See eligibility →

Active, not recruitingNot applicable

Fit-for-Fertility Multicenter Randomized Controlled Trial

Obesity, Infertility, FemaleCondition

Fit-For-Fertility program, Standard of careTreatment

Canada5 locations

Université de SherbrookeSponsor

Updated 2025-03-19 · NCT03908099See eligibility →

Active, not recruitingNot applicable

Impact of a Regional Program Agir Sur Sa SantE

Diabetes Mellitus, Type 2, ObesityCondition

Implementation of a new regional care frameworkTreatment

Canada1 locations

Université de SherbrookeSponsor

Updated 2024-12-09 · NCT02478853See eligibility →

Active, not recruitingNot applicable

Impact of an Integrated Obesity Management System on Patient's Care

ObesityCondition

2-day preceptorship on obesity managementTreatment

Canada1 locations

Université de SherbrookeSponsor

Updated 2024-12-05 · NCT00991640See eligibility →

Active, not recruitingNot applicable

Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development

Gestational Diabetes, Insulin ResistanceCondition

Intervention not listedTreatment

Canada1 locations

Université de SherbrookeSponsor

Updated 2024-10-18 · NCT01623934See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Sherbrooke, Canada

Current studies

Related cities